No results for ‘’
Aster DM Healthcare Ltd
₹761.05
(0.50%)
Mon, 25 May 2026, 04:32 pm
Health Services
Hospital/Nursing Management
24.5KAster DM Healthcare EV/EBITDA Ratio
| Particulars | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.13 | 23.33 | 17.35 | 46.25 | 18.63 | 28.30 | 157.61 | 4.49 |
| Price to book ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.98 | 2.43 | 1.45 | 2.02 | 2.48 | 2.70 | 4.47 | 7.05 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.17 | 0.98 | 0.55 | 0.79 | 0.96 | 4.02 | 5.51 | 5.84 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.63 | 18.65 | 4.67 | 4.85 | 8.21 | 7.13 | 0 | 55.86 |
| Enterprise value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 102.21B | 106.83B | 106.63B | 117.93B | 148.49B | 176.97B | 221.14B | 250.32B |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.11 | 11.96 | 8.25 | 10.52 | 9.65 | 38.42 | 37.21 | 32.07 |
| Debt to equity ratio | 0.29 | 0.49 | 0.65 | 0.97 | 0.73 | 7.91 | 1.47 | 0.83 | 0.87 | 1.71 | 1.42 | 1.24 | 1.28 | 0.30 | 0.59 |
| Return on equity % | 0 | 13.69 | 12.66 | 21.04 | 11.08 | -6.66 | 8.87 | 11.42 | 11.02 | 8.53 | 4.45 | 14.36 | 3.32 | 3.98 | 7.68 |
Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio
The Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Aster DM Healthcare Ltd's valuation, profitability, and overall financial performance. Tracking the Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Aster DM Healthcare Ltd (NSE: ASTERDM, BSE: 540975) is currently trading at ₹761.05, with a market capitalization of ₹395.95B. As a leading company in the Health services sector and Hospital/Nursing management industry, monitoring the Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio Current Value
The current Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio stands at 32.07.
The Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 32.07
- 2023: 37.21
- 2022: 38.42
- 2021: 9.65
- 2020: 10.52
The decline in Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Aster DM Healthcare Ltd.
Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Aster DM Healthcare Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.